Kimball Hall - May 24, 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Director
Signature: /s/ Chu Lee, Attorney-in-Fact
Stock symbol: VERA
Transactions as of: May 24, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/26/2022, 04:16 PM
Previous filing: Dec 13, 2021
Next filing: May 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+9.93K		$0.00	9.93K	May 24, 2022	Class A Common Stock	9.93K	$16.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Content

The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.